Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (321-330 of 551) with videos related to

Pageof 56
Sort By:
Breast Cancer Research and Treatment|April 1, 1988
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patientsS Iacobelli, E Arno, P Sismondi, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 24, 1999
Reproductive effects of dietary soy in female Wistar ratsD Gallo, F Cantelmo, M Distefano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparisonL Pierelli, A Perillo, S Greggi, et al.
Gynecologic Oncology|July 1, 1996
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomyP Benedetti-Panici, F Maneschi, G Scambia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Gynecologic Oncology|April 1, 1995
Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cellsG Scambia, R Della Bitta, P Benedetti Panici, et al.
British Journal of Cancer|October 29, 1998
In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescueL Pierelli, G Scambia, A Fattorossi, et al.
British Journal of Cancer|January 15, 1999
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell linesC Ferlini, G Scambia, M Marone, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1988
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvementF Battaglia, G Scambia, S Rossi, et al.
Gynecologic Oncology|December 15, 2012
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term resultsG Ferrandina, M G Distefano, R De Vincenzo, et al.
Pageof 56

Showing results (321-330 of 551) with videos related to

Sort By:
Pageof 56
Breast Cancer Research and Treatment|April 1, 1988
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patientsS Iacobelli, E Arno, P Sismondi, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 24, 1999
Reproductive effects of dietary soy in female Wistar ratsD Gallo, F Cantelmo, M Distefano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparisonL Pierelli, A Perillo, S Greggi, et al.
Gynecologic Oncology|July 1, 1996
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomyP Benedetti-Panici, F Maneschi, G Scambia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Gynecologic Oncology|April 1, 1995
Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cellsG Scambia, R Della Bitta, P Benedetti Panici, et al.
British Journal of Cancer|October 29, 1998
In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescueL Pierelli, G Scambia, A Fattorossi, et al.
British Journal of Cancer|January 15, 1999
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell linesC Ferlini, G Scambia, M Marone, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1988
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvementF Battaglia, G Scambia, S Rossi, et al.
Gynecologic Oncology|December 15, 2012
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term resultsG Ferrandina, M G Distefano, R De Vincenzo, et al.
Pageof 56